News
The Chief Executive of Eli Lilly has told the BBC that he is doubtful tariffs could bring manufacturing jobs to the US whilst ...
The Chief Executive of US pharmaceutical company Eli Lilly says it will be hard to come back from this moment.
18hon MSN
Eli Lilly is reaping the benefits from its innovation in diabetes and obesity management, with therapies like Mounjaro and ...
To what extent will health clinics go to keep selling in-demand weight-loss drugs now that the FDA has outlawed cheaper ...
Investors are nervous. As of 9:55 a.m. ET Wednesday morning, shares of Roche Holding ( RHHBY -2.81%) are down 2.3%, Eli Lilly ( LLY -4.38%) stock is off 3.2%, and AstraZeneca ( AZN -4.87%) is doing ...
But at the same time, industry leaders are bracing for the news that they think is inevitable given Trump’s declaration in ...
Explore more
We recently published a list of the 10 High Growth Dividend Paying Stocks to Invest in. In this article, we are going to take ...
Lately, however, Eli Lilly's stock has cooled. Shares have been essentially flat since July 2024. The market for GLP-1 ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...
Tobacco giant Altria (NYSE: MO) provides a tremendously high dividend yield of 7%, which is well above the S&P 500 index ...
In the first arrangement of its kind, Eli Lilly to connect patients through telemedicine to providers of Alzheimer’s drugs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results